Anil Jina

Anil S Jina, MD, serves as the Chief Medical Officer (fractional) at Prudentia Sciences since July 2023 and holds dual roles as Chief Medical Officer and President at uMed since April 2023, where the focus is on enabling a global network for clinical and real-world research. As an Executive in Residence at Iaso Ventures since December 2022, Anil S Jina drives innovation in neuroscience startups. Previously, Anil S Jina was Chief Medical Officer at Akili Interactive, leading the FDA clearance of a therapeutic video game and participating in significant financial ventures. Anil S Jina has also held senior roles at PPD and Axcella, and served as Chief Medical Officer at Evelo Biosciences and Shire. Anil S Jina's career includes extensive leadership in medical affairs and drug development at Sanofi and Pfizer. Anil S Jina earned an MB BCh BAO in Medicine from the Royal College of Surgeons in Ireland.